Vimarsana
Biggest News Aggregation in the World

Hui Gan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hui Gan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hui Gan Today - Breaking & Trending Today

Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia - Vimarsana News

Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia

GBM AGILE Adaptive Platform Trial Recruiting in Australia

Vail-area pickleballers pick up cash at Steamboat Springs tournament - Vimarsana News

Vail-area pickleballers pick up cash at Steamboat Springs tournament

Eight Vail-area pickleball players competed at the Steamboat Open Sept. 23-24, and a few returned with a nice chunk of change. Vail instructor Bruno Barrueto and fellow Peruvian-born pro Hercilio Cabieses won the $1500 open...

Telix Advances Development of Glioblastoma Therapy Program - Vimarsana News

Telix Advances Development of Glioblastoma Therapy Program

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company's glioblastoma...

Telix Pharmaceuticals Limited: Telix Advances Development of Glioblastoma Therapy Program - Vimarsana News

Telix Pharmaceuticals Limited: Telix Advances Development of Glioblastoma Therapy Program

MELBOURNE, Australia, March 23, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company's glioblastoma

Humanigen, Inc.: Humanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors following presentation of Phase 1 study results at EANM'21 - Vimarsana News

Humanigen, Inc.: Humanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors following presentation of Phase 1 study results at EANM'21

An abstract showing tumor specific targeting at all known tumor sites in glioblastoma patients, with no normal tissue uptake of ifabotuzumab, from a Phase 1 study will be presented at EANM'21